It is essential to note that it may have gastrointestinal side effects
ATTAIN-MAINTAIN Trial Study Design In the present study, researchers evaluated the safety and efficacy of orforglipron in body weight maintenance after treatment with injectables
But that was based on a homogenous population of largely white, fair-haired Australians
Breier A, Liffick E, Hummer TA, Vohs JL, Yang Z, Mehdiyoun NF, et al
The most common diagnoses in gastroenterology are a group of disorders known as Functional Gastrointestinal Disorders (FGIDs)
Here, we identify CNS sites activated by GIPR-Ab/GLP-1 and reveal key roles for both CNS GLP-1Rs and GIPRs to enable the full extent of weight loss and metabolic benefit